Title : Repeated Lusutrombopag Treatment for Thrombocytopenia in Patients with Chronic Liver Disease.

Pub. Date : 2021

PMID : 32841939






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND/AIMS: Lusutrombopag, a small-molecule thrombopoietin receptor agonist, is used to treat thrombocytopenia based on the results of a phase 3 trial, including data for single-use administration in patients with chronic liver disease (CLD) undergoing invasive procedures. lusutrombopag MPL proto-oncogene, thrombopoietin receptor Homo sapiens